Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
mig [2018/11/18 11:36]
sflitman [Migraine]
mig [2018/11/18 11:36]
sflitman [Migraine]
Line 4: Line 4:
  
 ^ Condition(s) ​ ^ Type of Drug  ^  Phase  ^  Add-On ​ ^  Placebo ​ ^  Duration ​ ^  Open-Label Extension ​ ^  ^ Condition(s) ​ ^ Type of Drug  ^  Phase  ^  Add-On ​ ^  Placebo ​ ^  Duration ​ ^  Open-Label Extension ​ ^
-| Treatment-resistant migraine prevention | Approved ​drug Emgality |  III  |  Yes  |  50%  |  3 months ​ |  3 months ​ |+| Treatment-resistant migraine prevention | Approved Emgality ​monthly injection ​|  III  |  Yes  |  50%  |  3 months ​ |  3 months ​ |
 | Abortive therapy for acute migraine | Oral combination of two approved drugs |  III  |  Yes  |  33%  |  12 weeks  |  None  | | Abortive therapy for acute migraine | Oral combination of two approved drugs |  III  |  Yes  |  33%  |  12 weeks  |  None  |
  
Print/export
QR Code
QR Code mig (generated for current page)